With the pharmaceutical company Sinopharm, a manufacturer has now announced details of the effectiveness of its corona vaccine for the first time in China. As the company announced on Wednesday, the vaccine should offer more than 79 percent protection against Covid-19 (79.34 percent).
The publication of the data is an important step for the final approval of the vaccine, of which states outside of China have already secured doses.
In China itself there are three other companies in addition to Sinopharm with Anhui Zhifei Longcom, CanSino and Sinovac, which are in the final phase of vaccine development. So far none of the companies has been granted final approval in Germany.
China had set the goal of being able to bring 600 million cans onto the market by the end of the year. Most recently, state media also spoke of wanting to vaccinate 50 million Chinese by mid-February.
For months now, restricted vaccinations have been carried out in China for certain population groups – for example by members of the military and hospital staff, but also by diplomats from state-owned corporations – even without final approval.